$809 Million is the total value of Boxer Capital, LLC's 24 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PTCT | PTC THERAPEUTICS INC | $73,960,000 | -27.0% | 2,155,000 | 0.0% | 9.14% | -18.7% | |
| MRTX | MIRATI THERAPEUTICS INC | $66,411,000 | -9.9% | 1,565,560 | 0.0% | 8.20% | +0.3% | |
| RCKT | ROCKET PHARMACEUTICALS INC | $29,137,000 | -39.8% | 1,966,051 | 0.0% | 3.60% | -33.0% | |
| CBAY | CYMABAY THERAPEUTICS INC | $16,480,000 | -29.0% | 2,094,000 | 0.0% | 2.04% | -20.9% | |
| KURA | KURA ONCOLOGY INC | $11,861,000 | -19.8% | 844,789 | 0.0% | 1.46% | -10.7% | |
| MEIP | MEI PHARMA INC | $7,691,000 | -38.7% | 2,913,091 | 0.0% | 0.95% | -31.8% | |
| KALV | KALVISTA PHARMACEUTICALS INC | $3,950,000 | -10.7% | 200,000 | 0.0% | 0.49% | -0.6% | |
| NVUS | NOVUS THERAPEUTICS INC | $519,000 | -65.7% | 324,383 | 0.0% | 0.06% | -61.9% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BEIGENE LTD | 34 | Q2 2024 | 15.6% |
| MIRATI THERAPEUTICS INC | 33 | Q4 2023 | 55.2% |
| ROCKET PHARMACEUTICALS INC | 26 | Q2 2024 | 5.4% |
| KURA ONCOLOGY INC. | 26 | Q2 2024 | 4.7% |
| DBV TECHNOLOGIES S A | 26 | Q2 2024 | 3.9% |
| IDEAYA BIOSCIENCES INC | 21 | Q2 2024 | 4.8% |
| AKERO THERAPEUTICS INC | 21 | Q2 2024 | 4.5% |
| MILESTONE PHARMACEUTICALS INC | 21 | Q2 2024 | 2.6% |
| MEI PHARMA INC | 21 | Q2 2023 | 1.4% |
| SPRINGWORKS THERAPEUTICS INC | 20 | Q2 2024 | 8.3% |
View Boxer Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| iTeos Therapeutics, Inc. | May 14, 2024 | 2,946,915 | 8.1% |
| Century Therapeutics, Inc. | April 22, 2024 | 4,901,603 | 5.8% |
| PMV Pharmaceuticals, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
| FATE THERAPEUTICS INC | February 12, 2024 | 6,171,000 | 6.3% |
| Tyra Biosciences, Inc. | February 08, 2024 | 6,448,359 | 12.3% |
| Mirati Therapeutics, Inc. | January 25, 2024 | ? | ? |
| Nkarta, Inc. | January 18, 2024 | 4,407,350 | 9.0% |
| Rain Oncology Inc. | December 18, 2023 | 2,933,152 | 9.9% |
| IDEAYA Biosciences, Inc. | February 14, 2023 | 2,202,812 | 4.6% |
| Milestone Pharmaceuticals Inc. | February 14, 2023 | 698,861 | 2.0% |
View Boxer Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-28 |
| 13F-HR | 2024-08-14 |
| SC 13G | 2024-07-18 |
| 13F-HR | 2024-05-15 |
| 4 | 2024-05-14 |
| SC 13D/A | 2024-05-14 |
| SC 13G | 2024-04-22 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-12 |
View Boxer Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.